Oestrogen, telomerase, ovarian ageing and cancer

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 1, 2010, Pages 78-82

  Li, He ^a   Simpson, Evan R ^b   Liu, Jun Ping ^a  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Oestrogen; Ovarian ageing; Ovarian cancer; Telomerase; Telomeres

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

CANCER RISK; CARCINOGENESIS; CELL AGING; CONFERENCE PAPER; ENZYME ACTIVITY; ESTROGEN THERAPY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; NONHUMAN; ONCOGENE C MYC; OVARY CANCER; RECEPTOR BINDING; TELOMERE;

AGING; CELL AGING; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; OVARIAN NEOPLASMS; OVARY; TELOMERASE; TELOMERE;

EID: 74049117090     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05238.x     Document Type: Conference Paper

References (59)

1. Weihua Z, Andersson S, Cheng G, Simpson ER, Warner M, Gustafsson JA. Update on estrogen signaling. FEBS Lett. 2003 546 : 17 24.
2. Lacey JV Jr., Mink PJ, Lubin JH et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 2002 288 : 334 341.
3. Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005 19 : 833 842.
4. Huang J, Li X, Yi P, Hilf R, Bambara RA, Muyan M. Targeting estrogen responsive elements (EREs): Design of potent transactivators for ERE-containing genes. Mol. Cell. Endocrinol. 2004 218 : 65 78.
5. Britt KL, Kerr J, O'Donnell L et al. Estrogen regulates development of the somatic cell phenotype in the eutherian ovary. FASEB J. 2002 16 : 1389 1397.
6. Blackburn EH. Switching and signaling at the telomere. Cell 2001 106 : 661 673.
7. Shay JW. Toward identifying a cellular determinant of telomerase repression. J. Natl Cancer Inst. 1999 91 : 4 6.
8. Wong JM, Collins K. Telomere maintenance and disease. Lancet 2003 362 : 983 988.
9. Reddel RR, Bryan TM. Alternative lengthening of telomeres: Dangerous road less travelled. Lancet 2003 361 : 1840 1841.
10. Bryan TM, Sperger JM, Chapman KB, Cech TR. Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax. Proc. Natl Acad. Sci. USA 1998 95 : 8479 8484.
11. Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 1998 16 : 1723 1730.
12. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995 269 : 1267 1270.
13. Bodnar AG, Ouellette M, Frolkis M et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998 279 : 349 352.
14. Bayne S, Liu JP. Hormones and growth factors regulate telomerase activity in ageing and cancer. Mol. Cell. Endocrinol. 2005 240 : 11 22.
15. Harley CB. Telomerase is not an oncogene. Oncogene 2002 21 : 494 502.
16. Leri A, Franco S, Zacheo A et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2003 22 : 131 139.
17. Wong KK, Maser RS, Bachoo RM et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 2003 421 : 643 648.
18. Greenberg RA, O'Hagan RC, Deng H et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 1999 18 : 1219 1226.
19. van der Burg B, van Selm-Miltenburg AJ, de Laat SW, van Zoelen EJ. Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol. Cell. Endocrinol. 1989 64 : 223 228.
20. Toda K, Takeda K, Okada T et al. Targeted disruption of the aromatase P450 gene (Cyp19) in mice and their ovarian and uterine responses to 17beta-oestradiol. J. Endocrinol. 2001 170 : 99 111.
21. Frasor J, Danes JM, Komm B, Chang KC, Lyttle CR, Katzenellenbogen BS. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 2003 144 : 4562 4574.
22. Bayne S, Jones ME, Li H, Liu JP. Potential roles for estrogen regulation of telomerase activity in aging. Ann. N. Y. Acad. Sci. 2007 1114 : 48 55.
23. Kyo S, Takakura M, Kanaya T et al. Estrogen activates telomerase. Cancer Res. 1999 59 : 5917 5921.
24. Misiti S, Nanni S, Fontemaggi G et al. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells. Mol. Cell. Biol. 2000 20 : 3764 3771.
25. Ling S, Zhou L, Li H et al. Effects of 17beta-estradiol on growth and apoptosis in human vascular endothelial cells: Influence of mechanical strain and tumor necrosis factor-alpha. Steroids 2006 71 : 799 808.
26. Blasco MA. Telomere length, stem cells and aging. Nat. Chem. Biol. 2007 3 : 640 649.
27. Zhang Z, Findlay JK, Carson RS, Herington AC, Burger HG. Transforming growth factor β enhances basal and FSH-stimulated inhibin production by rat granulosa cells in vitro. Mol. Cell. Endocrinol. 1988 58 : 161 166.
28. Gitay-Goren H, Kim IC, Miggans ST, Schomberg DW. Transforming growth factor beta modulates gonadotropin receptor expression in porcine and rat granulosa cells differently. Biol. Reprod. 1993 48 : 1284 1289.
29. Ke F-C, Chuang L-C, Lee M-T et al. The modulatory role of transforming growth factor β1 and androstenedione on follicle-stimulating hormone-induced gelatinase secretion and steroidogenesis in rat granulosa cells. Biol. Reprod. 2004 70 : 1292 1298.
30. Cassar L, Li H, Pinto AR, Nicholls C, Bayne S, Liu JP. Bone morphogenetic protein-7 inhibits telomerase activity, telomere maintenance, and cervical tumor growth. Cancer Res. 2008 68 : 9157 9166.
31. Cassar L, Nicholls C, Pinto AR, Li H, Liu JP. Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3. FASEB J. 2009 23 : 1880 1892.
32. Couse JF, Curtis Hewitt S, Korach KS. Receptor null mice reveal contrasting roles for estrogen receptor α and β in reproductive tissues. J. Steroid Biochem. Mol. Biol. 2000 74 : 287 296.
33. Palter SF, Tavares AB, Hourvitz A, Veldhuis JD, Adashi EY. Are estrogens of import to primate/human ovarian folliculogenesis? Endocr. Rev. 2001 22 : 389 424.
34. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes. Development 2000 127 : 4277 4291.
35. Kondoh K, Tsuji N, Asanuma K, Kobayashi D, Watanabe N. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-delta (12,14)-prostaglandin J(2)-induced apoptosis in cancer cells. Exp. Cell Res. 2007 313 : 3486 3496.
36. Grasselli A, Nanni S, Colussi C et al. Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase. Circ. Res. 2008 103 : 34 42.
37. Piontkewitz Y, Sundfeldt K, Hedin L. The expression of c-myc during follicular growth and luteal formation in the rat ovary in vivo. J. Endocrinol. 1997 152 : 395 406.
38. Santos GF, Scott GK, Lee WM, Liu E, Benz C. Estrogen-induced post-transcriptional modulation of c-myc proto-oncogene expression in human breast cancer cells. J. Biol. Chem. 1988 263 : 9565 9568.
39. Sarkar P, Shiizaki K, Yonemoto J, Sone H. Activation of telomerase in BeWo cells by estrogen and 2,3,7,8-tetrachlorodibenzo-p-dioxin in co-operation with c-Myc. Int. J. Oncol. 2006 28 : 43 51.
40. Li H, Cao Y, Berndt MC, Funder JW, Liu JP. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene 1999 18 : 6785 6794.
41. Kanaya T, Kyo S, Hamada K et al. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin. Cancer Res. 2000 6 : 1239 1247.
42. Shats I, Milyavsky M, Tang X et al. p53-dependent down-regulation of telomerase is mediated by p21waf1. J. Biol. Chem. 2004 279 : 50976 50985.
43. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ERA. Transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005 307 : 1625 1630.
44. Soslow RA. Histologic subtypes of ovarian carcinoma: An overview. Int. J. Gynecol. Pathol. 2008 27 : 161 174.
45. Kommoss F, Pfisterer J, Thome M, Schafer W, Sauerbrei W, Pfleiderer A. Steroid receptors in ovarian carcinoma: Immunohistochemical determination may lead to new aspects. Gynecol. Oncol. 1992 47 : 317 322.
46. Osborne CK, Schiff R. Estrogen-receptor biology: Continuing progress and therapeutic implications. J. Clin. Oncol. 2005 23 : 1616 1622.
47. Li YF, Hu W, Fu SQ, Li JD, Liu JH, Kavanagh JJ. Aromatase inhibitors in ovarian cancer: Is there a role? Int. J. Gynecol. Cancer 2008 18 : 600 614.
48. Munstedt K, Steen J, Knauf AG, Buch T, von Georgi R, Franke FE. Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 2000 89 : 1783 1791.
49. Geisler JP, Wiemann MC, Miller GA, Geisler HE. Estrogen and progesterone receptor status as prognostic indicators in patients with optimally cytoreduced stage IIIc serous cystadenocarcinoma of the ovary. Gynecol. Oncol. 1996 60 : 424 427.
50. Suga S et al. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer. Gynecol. Oncol. 2007 105 : 341 350.
51. Jabara AG. Induction of canine ovarian tumours by diethylstilboestrol and progesterone. Aust. J. Exp. Biol. Med. Sci. 1962 40 : 139 152.
52. Bai W, Oliveros-Saunders B, Wang Q, Acevedo-Duncan ME, Nicosia SV. Estrogen stimulation of ovarian surface epithelial cell proliferation. In Vitro Cell. Dev. Biol. Anim. 2000 36 : 657 666.
53. Silva EG, Tornos C, Deavers M, Kaisman K, Gray K, Gershenson D. Induction of epithelial neoplasms in the ovaries of guinea pigs by estrogenic stimulation. Gynecol. Oncol. 1998 71 : 240 246.
54. Chow SN, Chien CH, Chen CT. Molecular biology of human ovarian cancer. Int. Surg. 1996 81 : 152 157.
55. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur. J. Cancer 1997 33 : 787 791.
56. Shay JW, Wright WE. Senescence and immortalization. Role of telomeres and telomerase. Carcinogenesis 2005 26 : 867 874.
57. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc. Natl Acad. Sci. USA 1994 91 : 2900 2904.
58. Shay JW, Wright WE. Hallmarks of telomeres in ageing research. J. Pathol. 2007 211 : 114 123.
59. Robker RL, Richards JS. Hormone-induced proliferation and differentiation of granulosa cells. A coordinated balance of the cell cycle regulators cyclin D2 and p27Kip1. Mol. Endocrinol. 1998 12 : 924 940.